• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-205 通过调控 E2F1 蛋白抑制黑色素瘤细胞增殖并诱导其衰老。

miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.

机构信息

California Pacific Medical Center Research Institute, San Francisco, California 94107, USA.

出版信息

J Biol Chem. 2011 May 13;286(19):16606-14. doi: 10.1074/jbc.M111.227611. Epub 2011 Mar 24.

DOI:10.1074/jbc.M111.227611
PMID:21454583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3089503/
Abstract

MicroRNAs (miRNAs) regulate gene expression by repressing translation or directing sequence-specific degradation of complementary mRNA. Here, we report that expression of miR-205 is significantly suppressed in melanoma specimens when compared with nevi and is correlated inversely with melanoma progression. miRNA target databases predicted E2F1 and E2F5 as putative targets. The expression levels of E2F1 and E2F5 were correlated inversely with that of miR-205 in melanoma cell lines. miR-205 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequences complementary to either E2F1 or E2F5. Overexpression of miR-205 in melanoma cells reduced E2F1 and E2F5 protein levels. The proliferative capacity of melanoma cells was suppressed by miR-205 and mediated by E2F-regulated AKT phosphorylation. miR-205 overexpression resulted in induction of apoptosis, as evidenced by increased cleaved caspase-3, poly-(ADP-ribose) polymerase, and cytochrome c release. Stable overexpression of miR-205 suppressed melanoma cell proliferation, colony formation, and tumor cell growth in vivo and induced a senescence phenotype accompanied by elevated expression of p16INK4A and other markers for senescence. E2F1 overexpression in miR-205-expressing cells partially reversed the effects on melanoma cell growth and senescence. These results demonstrate a novel role for miR-205 as a tumor suppressor in melanoma.

摘要

微小 RNA(miRNAs)通过抑制翻译或指导互补 mRNA 的序列特异性降解来调节基因表达。在这里,我们报告 miR-205 在黑色素瘤标本中的表达明显受到抑制,与痣相比,并且与黑色素瘤的进展呈负相关。miRNA 靶数据库预测 E2F1 和 E2F5 是潜在的靶标。E2F1 和 E2F5 的表达水平与黑色素瘤细胞系中 miR-205 的表达水平呈负相关。miR-205 显著抑制含有与 E2F1 或 E2F5 互补的 3'UTR 序列的报告质粒的荧光素酶活性。在黑色素瘤细胞中过表达 miR-205 可降低 E2F1 和 E2F5 蛋白水平。miR-205 通过 E2F 调节的 AKT 磷酸化抑制黑色素瘤细胞的增殖能力。miR-205 的过表达导致凋亡的诱导,如增加的 cleaved caspase-3、多聚(ADP-核糖)聚合酶和细胞色素 c 释放所证明的那样。miR-205 的稳定过表达抑制黑色素瘤细胞增殖、集落形成和体内肿瘤细胞生长,并诱导衰老表型,同时伴有 p16INK4A 和其他衰老标志物的表达升高。在表达 miR-205 的细胞中过表达 E2F1 部分逆转了对黑色素瘤细胞生长和衰老的影响。这些结果表明 miR-205 在黑色素瘤中作为肿瘤抑制因子的新作用。

相似文献

1
miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.miRNA-205 通过调控 E2F1 蛋白抑制黑色素瘤细胞增殖并诱导其衰老。
J Biol Chem. 2011 May 13;286(19):16606-14. doi: 10.1074/jbc.M111.227611. Epub 2011 Mar 24.
2
Antitumor activity of miR-1280 in melanoma by regulation of Src.miR-1280通过调控Src在黑色素瘤中的抗肿瘤活性。
Mol Ther. 2015 Jan;23(1):71-8. doi: 10.1038/mt.2014.176. Epub 2014 Sep 8.
3
Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells.抑癌 microRNA-203 通过靶向人黑色素瘤细胞中的 E2F3 蛋白诱导衰老。
J Biol Chem. 2012 Apr 6;287(15):11769-77. doi: 10.1074/jbc.M111.325027. Epub 2012 Feb 21.
4
MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.微小RNA-330作为肿瘤抑制因子,通过E2F1介导的Akt磷酸化抑制作用诱导前列腺癌细胞凋亡。
Oncogene. 2009 Sep 24;28(38):3360-70. doi: 10.1038/onc.2009.192. Epub 2009 Jul 13.
5
MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells.miRNA-329 通过靶向 E2F1 抑制神经胶质瘤细胞的增殖。
J Transl Med. 2013 Jul 17;11:172. doi: 10.1186/1479-5876-11-172.
6
MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.微小RNA-34a靶向丝状肌动蛋白结合蛋白2(FMNL2)和E2F5并抑制结直肠癌的进展。
Exp Mol Pathol. 2015 Aug;99(1):173-9. doi: 10.1016/j.yexmp.2015.06.014. Epub 2015 Jun 20.
7
The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.miR-18b 在 MDM2-p53 通路信号转导和黑色素瘤进展中的作用。
J Natl Cancer Inst. 2013 Mar 20;105(6):433-42. doi: 10.1093/jnci/djt003. Epub 2013 Jan 30.
8
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.微小RNA-449a可导致前列腺癌细胞发生依赖于视网膜母细胞瘤蛋白的细胞周期停滞和衰老。
Oncotarget. 2010 Sep;1(5):349-58. doi: 10.18632/oncotarget.167.
9
5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.5' 微小 RNA-183-5p|+2 通过与 E2F1 的负反馈环发挥肿瘤抑制活性。
J Exp Clin Cancer Res. 2022 Jun 2;41(1):190. doi: 10.1186/s13046-022-02380-8.
10
miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.微小RNA-218通过CDK6/细胞周期蛋白D1/E2F1轴以反馈环的形式抑制胃癌细胞周期进程。
Cancer Lett. 2017 Sep 10;403:175-185. doi: 10.1016/j.canlet.2017.06.006. Epub 2017 Jun 17.

引用本文的文献

1
LEADR, a p63 target, dampens interferon signalling in bladder cancer.LEADR是一种p63靶点,可抑制膀胱癌中的干扰素信号传导。
Cell Death Discov. 2025 Jun 3;11(1):264. doi: 10.1038/s41420-025-02546-1.
2
The regulation of LRPs by miRNAs in cancer: influencing cancer characteristics and responses to treatment.微小RNA在癌症中对低密度脂蛋白受体相关蛋白的调控:影响癌症特征及对治疗的反应
Cancer Cell Int. 2025 May 17;25(1):182. doi: 10.1186/s12935-025-03804-z.
3
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.乳腺癌中的非编码RNA:诊断和治疗意义
Int J Mol Sci. 2024 Dec 26;26(1):127. doi: 10.3390/ijms26010127.
4
miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer.miR-205通过靶向雌激素受体共激活因子MED1调控人乳腺癌中他莫昔芬耐药性。
Cancers (Basel). 2024 Nov 28;16(23):3992. doi: 10.3390/cancers16233992.
5
The E2F family: a ray of dawn in cardiomyopathy.E2F家族:心肌病领域的一线曙光。
Mol Cell Biochem. 2025 Feb;480(2):825-839. doi: 10.1007/s11010-024-05063-4. Epub 2024 Jul 10.
6
A New Approach to Melanoma Treatment: microRNAs.一种新的黑素瘤治疗方法:microRNAs。
Curr Top Med Chem. 2024;24(16):1362-1376. doi: 10.2174/0115680266291290240417081544.
7
Improving targeted small molecule drugs to overcome chemotherapy resistance.改进靶向小分子药物以克服化疗耐药性。
Cancer Rep (Hoboken). 2024 Jan;7(1):e1945. doi: 10.1002/cnr2.1945. Epub 2023 Nov 22.
8
Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis.从 CSCs 中揭示 miRNA 的潜力,作为乳腺癌诊断和预后的新兴临床工具。
Int J Mol Sci. 2023 Nov 6;24(21):16010. doi: 10.3390/ijms242116010.
9
Blood-based microRNAs as Potential Diagnostic Biomarkers for Melanoma: A Meta-Analysis.基于血液的 microRNAs 作为黑色素瘤潜在诊断生物标志物的 Meta 分析。
Curr Med Chem. 2024;31(31):5083-5096. doi: 10.2174/0929867330666230509110111.
10
Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics.透过镜子:卵巢癌诊断的最新见解
Diagnostics (Basel). 2023 Feb 14;13(4):713. doi: 10.3390/diagnostics13040713.

本文引用的文献

1
Signatures of microRNAs and selected microRNA target genes in human melanoma.人类黑色素瘤中的 microRNAs 和选定的 microRNA 靶基因的特征。
Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4.
2
Functional modulation of IGF-binding protein-3 expression in melanoma.黑色素瘤中 IGF 结合蛋白-3 表达的功能调节。
J Invest Dermatol. 2010 Aug;130(8):2071-9. doi: 10.1038/jid.2010.70. Epub 2010 Apr 1.
3
E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.E2F5 状态显著提高上皮性卵巢癌的恶性程度诊断能力。
BMC Cancer. 2010 Feb 24;10:64. doi: 10.1186/1471-2407-10-64.
4
E2F1 in melanoma progression and metastasis.E2F1 在黑色素瘤的进展和转移中的作用。
J Natl Cancer Inst. 2010 Jan 20;102(2):127-33. doi: 10.1093/jnci/djp458. Epub 2009 Dec 21.
5
MicroRNA-mediated control in the skin.微小 RNA 介导的皮肤调控。
Cell Death Differ. 2010 Feb;17(2):229-35. doi: 10.1038/cdd.2009.92. Epub 2009 Jul 17.
6
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.皮肤黑色素瘤中RUNX3肿瘤抑制基因表达的调控
Clin Cancer Res. 2009 May 1;15(9):2988-94. doi: 10.1158/1078-0432.CCR-08-3172. Epub 2009 Mar 31.
7
MicroRNAs--the micro steering wheel of tumour metastases.微小RNA——肿瘤转移的微小方向盘
Nat Rev Cancer. 2009 Apr;9(4):293-302. doi: 10.1038/nrc2619. Epub 2009 Mar 5.
8
Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome.E2F-5的过表达与病理性基底表型及更差的临床预后相关。
Br J Cancer. 2009 Mar 10;100(5):764-71. doi: 10.1038/sj.bjc.6604900.
9
MicroRNAs: novel biomarkers for human cancer.微小RNA:人类癌症的新型生物标志物。
Clin Chem. 2009 Apr;55(4):623-31. doi: 10.1373/clinchem.2008.112805. Epub 2009 Feb 26.
10
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.异常的miR-182表达通过抑制FOXO3和小眼相关转录因子促进黑色素瘤转移。
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9. doi: 10.1073/pnas.0808263106. Epub 2009 Feb 2.